XML 20 R11.htm IDEA: XBRL DOCUMENT v3.10.0.1
NOTE 5 - SHAREHOLDERS' EQUITY
6 Months Ended
Jun. 30, 2018
Notes  
NOTE 5 - SHAREHOLDERS' EQUITY Summary of Stock Option and Warrant Activity The following is a summary of the Company’s stock option and warrant activity as of June 30, 2018 and changes during the year then ended:

 

 

 

 

Weighted-Average

Aggregate

 

 

Weighted-Average

Remaining Contractual

Intrinsic

 

Shares

Exercise Price (a)

Term (Years)

Value

Outstanding, December 31, 2017

4,058,774 

$1.29 

5.59 

$577,725 

Issued during period

250,000 

$0.01 

6.51 

$47,500 

Expired during period

0 

 

 

 

Outstanding, June 30, 2018

4,308,774 

$1.22 

5.18 

$308,975 

Exercisable, June 30, 2018

3,058,774 

$0.96 

5.04 

$308,975 

 

 

 

 

 

Note:

(a) The Weighted-Average Exercise Price column excludes those warrants that have an exercise price for the common stock priced at the Capital Raise Price Per Share.

 

Shares Issued During Period – On April 1, 2018, the Company issued to a director and to an independent contractor rights to purchase warrants, for an aggregate purchase price of $2.00, an aggregate of 250,000 shares of common stock of the Company, at an exercise price of $0.01 per share, such warrants to be fully vested and to be exercisable on or prior to December 31, 2024.

 

Assignment and Exercise of Stock Option Agreement Reference is hereby made to that certain Stock Option Agreement (the “SOA”) dated November 4, 2010, between Cogility and Gerard M. Jacobs, that was entered into pursuant to the Agreement by and among Deborah Sue Ghourdjian Separate Property Trust, Matthew Ghourdjian, Cogility, Gerard M. Jacobs, Joshua A. Bloom, Roger S. Greene, James S. Jacobs, Michael D. McCaffrey, Vincent J. Mesolella, Richard E. Morrissy, and Acquired Sales.

 

Cogility was acquired by Acquired Sales in September 2011. Pursuant to the terms and conditions of that acquisition and the SOA, Gerard M. Jacobs or his assignees or heirs was granted the right to purchase 100,000 shares of common stock of Acquired Sales at the purchase price of $0.001 per share, or an aggregate purchase price of $100.

 

For valuable consideration received, Gerard M. Jacobs assigned the SOA to his affiliate Miss Mimi Corporation (“Miss Mimi”), effective as of May 18, 2016. Miss Mimi notified Acquired Sales effective as of May 18, 2016, that Miss Mimi exercised the SOA

 

 

Acquired Sales Corp.

Notes to the Condensed Financial Statements

(Unaudited)

 

and thereby purchased all 100,000 shares of common stock of Acquired Sales covered by the SOA, for the aggregate purchase price of $100, with the purchase price paid in the form of cashier’s check from Miss Mimi payable to Acquired Sales.

 

Financing Warrants – Through December 31, 2012, the Company issued 938,000 warrants in connection with the issuance of notes payable primarily to related parties. 460,000 of these warrants expired on March 31, 2016. In February and March 2017, 162,500 of these warrants expired. Then, in April and July 2017, 87,500 of these warrants expired. At June 30, 2017, 228,000 warrants were outstanding with a weighted-average exercise price of $3.33 per share, a weighted-average remaining contractual term of 0.17 years and an aggregate intrinsic value of $0. These remaining warrants expired by the end of 2017.